IL43562A - Pharmaceutical formulations containing allopurinol as inhibitor of xanthine oxidase - Google Patents
Pharmaceutical formulations containing allopurinol as inhibitor of xanthine oxidaseInfo
- Publication number
- IL43562A IL43562A IL43562A IL4356273A IL43562A IL 43562 A IL43562 A IL 43562A IL 43562 A IL43562 A IL 43562A IL 4356273 A IL4356273 A IL 4356273A IL 43562 A IL43562 A IL 43562A
- Authority
- IL
- Israel
- Prior art keywords
- tablet formulation
- formulation according
- allopurinol
- particle size
- inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5105072A GB1445983A (en) | 1972-11-06 | 1972-11-06 | Pharmaceutical formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL43562A0 IL43562A0 (en) | 1974-03-14 |
| IL43562A true IL43562A (en) | 1976-08-31 |
Family
ID=10458450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL43562A IL43562A (en) | 1972-11-06 | 1973-11-05 | Pharmaceutical formulations containing allopurinol as inhibitor of xanthine oxidase |
Country Status (14)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1499672A (en) * | 1974-02-14 | 1978-02-01 | Wellcome Found | Tablet formulation |
| US4143129A (en) | 1975-10-11 | 1979-03-06 | Lilly Industries Limited | Cephalexin tablets |
| FR2608045B1 (fr) * | 1986-12-12 | 1990-03-02 | Chauvin Laboratoires | Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB975850A (en) * | 1955-08-10 | 1964-11-18 | Wellcome Found | Xanthine oxidase inhibitors |
-
1972
- 1972-11-06 GB GB5105072A patent/GB1445983A/en not_active Expired
-
1973
- 1973-11-05 IL IL43562A patent/IL43562A/en unknown
- 1973-11-05 JP JP12430373A patent/JPS577127B2/ja not_active Expired
- 1973-11-05 AU AU62177/73A patent/AU467532B2/en not_active Expired
- 1973-11-05 ZA ZA00738489A patent/ZA738489B/xx unknown
- 1973-11-05 CH CH1552773A patent/CH583734A5/xx not_active IP Right Cessation
- 1973-11-05 FR FR7339183A patent/FR2205309B1/fr not_active Expired
- 1973-11-05 DE DE19732355204 patent/DE2355204A1/de active Pending
- 1973-11-05 CA CA185,010A patent/CA975297A/en not_active Expired
- 1973-11-05 CY CY940A patent/CY940A/xx unknown
- 1973-11-05 BE BE137437A patent/BE806946A/xx not_active IP Right Cessation
-
1977
- 1977-12-02 KE KE2807A patent/KE2807A/xx unknown
-
1978
- 1978-01-05 HK HK12/78A patent/HK1278A/xx unknown
- 1978-12-31 MY MY1978180A patent/MY7800180A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MY7800180A (en) | 1978-12-31 |
| CA975297A (en) | 1975-09-30 |
| GB1445983A (en) | 1976-08-11 |
| DE2355204A1 (de) | 1974-05-16 |
| FR2205309A1 (US06653308-20031125-C00199.png) | 1974-05-31 |
| ZA738489B (en) | 1975-02-26 |
| BE806946A (fr) | 1974-05-06 |
| FR2205309B1 (US06653308-20031125-C00199.png) | 1976-04-09 |
| AU6217773A (en) | 1975-05-08 |
| HK1278A (en) | 1978-01-13 |
| CY940A (en) | 1978-06-23 |
| AU467532B2 (en) | 1975-12-04 |
| JPS49133517A (US06653308-20031125-C00199.png) | 1974-12-21 |
| KE2807A (en) | 1978-02-17 |
| IL43562A0 (en) | 1974-03-14 |
| JPS577127B2 (US06653308-20031125-C00199.png) | 1982-02-09 |
| CH583734A5 (US06653308-20031125-C00199.png) | 1977-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1381588A (en) | Process for the preparation of porous tablets | |
| DE3461054D1 (en) | Divisible tablet with sustained release of the active ingredient, and process for its production | |
| FI872577A (fi) | Menetelmä terapeuttisesti käyttökelpoisten, hydrofobisen tai niukkaliukoisen aineen mikronisoitujen, hydrofilisoitujen hiukkasten valmistamiseksi | |
| MY101847A (en) | Composition for solid pharmaceutical preparations of active vitamins d 3 and process for preparation thereof. | |
| AU1729297A (en) | Solid formulations containing trehalose | |
| CA983030A (en) | 2-(substituted pyrrolidino)-8-lower alkyl-5,8-dihydro-5-oxopyrido(2,3-d) pyrimidine-6-carboxylic acid derivatives, and process for the preparation of the same | |
| IL43562A (en) | Pharmaceutical formulations containing allopurinol as inhibitor of xanthine oxidase | |
| CA1018890A (en) | Hard pharmaceutical tablets containing orally active penicillin or cephalosporin and heavy magnesium carbonate | |
| GB1457546A (en) | Pharmaceutical preparations comprising cephalosporin derivatives | |
| GB1202148A (en) | Pharmaceutical compositions | |
| GB1363047A (en) | Pyrimidine derivative process for its preparation and its use as a medicament | |
| GB1315177A (en) | Antibiotic and process for preparing same | |
| IL44877A (en) | Allopurinol tablet formulation | |
| ZA712798B (en) | New,pharmaceutically active 2,3-diazabicyclo(5.4.0)undecapentaene derivative and process for preparing same | |
| IE39557L (en) | TABLETS CONTAINING ß-LACTAM ANTIBIOTICS AND UREA | |
| IE41358B1 (en) | Acyloxymethyl cephalosporin esters | |
| GB1391554A (en) | Pharmaceutical compositions and process for their preparation | |
| JPS5247984A (en) | Stabilization of elastase | |
| GB1330545A (en) | Pharmaceutical preparations | |
| CA921924A (en) | Process for the preparation of compounds having a 2,3,5,6-tetrahydro-imidazo(2,1-b)thiazole ring system | |
| GB1360032A (en) | 2-thio-5-azocytosine and its nucleosides | |
| CA846170A (en) | PROCESS FOR THE PREPARATION OF 7-(.alpha.-(4-PYRIDYLTHIO) ACETAMIDO) CEPHALOSPORINS | |
| IE34501L (en) | Sulphonyl-imidazolidines | |
| JPS5290687A (en) | Highly active glucoseisomerase concentrate having high storage stabili ty | |
| IE34386L (en) | Acetylsalicylic acid-containing composition |